PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. CMS negotiation may lead to additional savings for beneficiaries and for the Medicare program.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually.

Medical 98

Medical Manufacturing Insurance Side effects 98

PM360

APRIL 7, 2023

Most immediately, it will add confusion in the healthcare space,” explains Daniel Sontupe, Associate Partner, Managing Director, The Bloc Value Builders. This will create confusion in the marketplace and may possibly lead to delivery of misinformation to healthcare providers (HCPs) regarding a brand’s drug coverage,” Bambalas says.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

LEVO Health

JULY 15, 2024

billion by 2027. This growth presents a significant opportunity for healthcare organizations and businesses, but it also means the market is becoming increasingly saturated. Given their effectiveness, GLP-1 medications have gained popularity, leading to a surge in market demand. In 2021, the GLP-1 market was valued at $16.53

Marketing 52

Marketing Side effects Education Medical 52

European Pharmaceutical Review

FEBRUARY 22, 2023

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. the enteric coating and the capsule dissolve.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Safety Pharmaceutical 105

Clarivate

OCTOBER 25, 2023

The dearth of cancer drugs (only blood cancer drug Imbruvica made this first list) stems from CMS only pursuing negotiations for Part D drugs in 2026 and 2027, then expanding to Part B drugs in 2028. Part D cannot cover drugs covered under Part A or Part B , forcing them to be addressed separately.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Pharmaceutical Technology

FEBRUARY 6, 2023

Leading up to 2023, experts have said a company’s financial wellbeing may depend on its economic position when the market shifted. Bexotegrast is an oral small molecule that inhibits αvβ6/αvβ1. The drug is under development for the treatment of the two rare diseases idiopathic pulmonary fibrosis (IPF) and primary sclerosing cholangitis (PSC).

Marketing 59

Marketing Pharmaceutical FDA Prospecting 59

Evolve Your Success

OCTOBER 31, 2023

Tune in and discover how one individual’s dedication can truly make a difference in the world of healthcare. By 2027, they are projected to be about $10 billion. Honestly, because it’s temporary, when we get ready to take out the temporary leads, some of the patients are like, “I don’t want that removed.”

Engineering 130

Engineering Sales Medical sales Medical 130

World of DTC Marketing

JUNE 4, 2021

Mike always battled weight issues, but since he went out on disability, he had gained more weight, leading to diabetes. An unhealthy diet is one of the leading risk factors for poor health and accounts for up to 45% of all deaths from these cardiometabolic diseases, the researchers noted. That’s about $375 per month.

Food 207

Food Insurance Leads Medical 207

PM360

JUNE 29, 2022

Healthcare and pharma companies are watching this trend and refining their strategies to meet tomorrow’s health consumer. What if you scan a QR code on the box or bottle and it would trigger an approval from your healthcare provider? Walmart has recently focused on expanding its virtual healthcare presence.

Retail 97

Retail Marketing Healthcare Healthcare 97

Impetus Digital

MARCH 15, 2024

In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers (2).

Recruitment 78

Recruitment Patients Healthcare Provider Healthcare 78

PM360

DECEMBER 14, 2022

In its latest venture into the healthcare arena, Amazon is reaching out directly to the consumer via its soon-to-be-launched Amazon Clinic , a virtual health service for patients to see licensed clinicians about common medical issues. billion euros into its new facility where it is planning to hire 400 and 500 new personal by 2027.

Medical 52

Medical Manufacturing Healthcare Healthcare 52

Medico Reach

FEBRUARY 8, 2023

Hence, looking closer at the future trends in pharma industry only makes sense for businesses to stay afloat in the healthcare market. Here are some more applications of AI in healthcare and pharma Medicines discovery and design can improve drastically. billion by 2027. billion in big data analytics.

Pharma 52

Pharma Medicine Marketing Prospecting 52

PM360

SEPTEMBER 21, 2023

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. 1 We have been improving patient affordability for over a decade, across generic and brand medications, including specialty treatments—sometimes by more than 50%.

Prescription 52

Prescription Medical Patients Distribution 52

Pharmaceutical Technology

APRIL 24, 2023

The rise of biologics In the lead-up to the 2020 boom, Swiss drugmaker Roche spent some $11 billion on biotechnology research and development in 2018. Syngene, which is among the leading CRDMOs in India, has biologics facilities that can produce a large array of products across mammalian and microbial platforms.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52

European Pharmaceutical Review

OCTOBER 12, 2023

So, by the time the facility is operational, anticipated for 2027, it has potential to transform access for clinical phase development of cell therapies in the region. Commercially, establishment of the RNA manufacturing facility will help to attract inward investment and promote resilience and sustainable growth into UK healthcare.

Pharmaceutical manufacturing 104

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 104

pharmaphorum

JANUARY 16, 2023

The present article focuses on opportunity, the unmet need which lies at the heart of better healthcare provision, and two areas of growth and opportunity: Point of Care Diagnostics, and the new pharmacotherapy classes which will commercialise for the first time in 2023. Innovation will power the market.

FDA 98

FDA Healthcare Healthcare Medicine 98

European Pharmaceutical Review

MARCH 4, 2024

percent through 2027. These actions occur at both the delivery site and other systemic locations, thereby promoting an immunogenic response that leads to cancer cell death. Anna has a medical degree and a postgraduate degree in healthcare management and is an expert in all stages of drug development. References 1.

Food and Drug Administration 98

Food and Drug Administration Transportation FDA Medical 98

Star OUTiCO

FEBRUARY 18, 2022

A Global Data survey reports that 35% of pharma professionals think that the pandemic increased the speed of digital transformation by five years [1], and global healthcare budgets reflect this in their apportioning of spend to digital-related improvements. The European Union’s EU4Health 2021-2027 budget, for example, allocates €5.3

Pharma 52

Pharma Healthcare Healthcare Patients 52

PM360

DECEMBER 12, 2024

In an insightful interview, leaders from the forefront of healthcare innovation Deepak Mittal , CEO of NextGen Invent ; Partha Anbil , SVP & Practice Leader at WNS Global; and Dr. William N. billion by 2027, growing at a CAGR of 25.8%. AI-based assistants have shown a significant impact on cancer care. Dr. William N.

Healthcare 52

Healthcare Healthcare Leads Medical 52